Results 181 to 190 of about 488,068 (360)

A Nationwide Danish Comparative Effectiveness Study of GLP‐1 RA, SGLT2i and DPP‐4i Treatment on Risk of Stroke, Myocardial Infarction and Mortality in Type 2 Diabetes

open access: yesEndocrinology, Diabetes &Metabolism, Volume 9, Issue 1, January 2026.
New users of GLP‐1 RA in type 2 diabetes had a lower risk of stroke and new users of GLP‐1 RA and SGLT2i in type 2 diabetes had a lower risk of mortality in comparison with new users of DPP‐4i in routine clinical settings. There were no differences in myocardial infarction.
Sidsel Hastrup   +5 more
wiley   +1 more source

No relationship between total kindey volume class or genotype and 24h blood pressure control in adult ADPKD patients [PDF]

open access: yes, 2018
Allamani, Mandelina   +4 more
core   +2 more sources

Serum microRNA profiles in patients with autosomal dominant polycystic kidney disease show systematic dysregulation partially reversible by hemodialysis

open access: gold, 2019
Beata Małachowska   +5 more
openalex   +1 more source

Monkeys mutant for PKD1 recapitulate human autosomal dominant polycystic kidney disease [PDF]

open access: gold, 2019
Tomoyuki Tsukiyama   +20 more
openalex   +1 more source

Recent Developments in Capillary and Microchip Electroseparations of Peptides (2023–mid 2025)

open access: yesELECTROPHORESIS, Volume 47, Issue 1, Page 106-136, January 2026.
ABSTRACT This review presents a comprehensive overview of the developments and applications of high‐performance capillary and microchip electromigration methods (zone electrophoresis in a free solution or in sieving media, isotachophoresis, isoelectric focusing, affinity electrophoresis, electrokinetic chromatography, and electrochromatography) for ...
Václav Kašička
wiley   +1 more source

Weight‐Reduction and Safety Profile of Once‐Weekly Non‐Comparable Biotherapeutic Subcutaneous Semaglutide Among People With Obesity: A Real‐World Retrospective Study

open access: yesHealth Science Reports, Volume 9, Issue 1, January 2026.
ABSTRACT Background and Aims Semaglutide, a once‐weekly injectable glucagon‐like peptide, showed double‐digit weight reduction with an acceptable safety profile in clinical trials and real‐world studies. The efficacy and safety of non‐comparable biotherapeutic (NCB) semaglutide are not adequately reported. Our study aimed to assess the weight reduction
Md Rakibul Hasan   +2 more
wiley   +1 more source

Organoids in Cancer Research and Regenerative Medicine: Current Status, Challenges, and Future Prospects

open access: yesMedComm, Volume 7, Issue 1, January 2026.
The management of cancer and tissue regeneration remains a substantial challenge to global health. Organoids, which are stem cell‐derived three‐dimensional multicellular structures, are revolutionizing biomedical research. Therefore, this review highlights their applications in cancer research and regenerative medicine, while discussing current ...
Ruiyang Li   +5 more
wiley   +1 more source

Tolvaptan in Later‐Stage Autosomal Dominant Polycystic Kidney Disease

open access: yesNew England Journal of Medicine, 2017
V. Torres   +10 more
semanticscholar   +1 more source

Polycystin 2 is increased in disease to protect against stress-induced cell death [PDF]

open access: yes, 2020
Brill, Allison L.   +13 more
core   +1 more source

Psychometric analyses of patient-reported outcome instruments for autosomal dominant polycystic kidney disease [PDF]

open access: bronze, 2013
Jason C. Cole   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy